Cours Gene Biotherapeutics, Inc. Other OTC
Actions
CRXM
US8767671048
Recherche biotechnologique et médicale
CA 2019 | - | CA 2020 | - | Capitalisation | 551 k 499 k |
---|---|---|---|---|---|
Résultat net 2019 | - 0 | Résultat net 2020 | - 0 | VE / CA 2019 | - |
Dette nette 2019 | 1,12 M 1,02 M | Dette nette 2020 | 874 k 792 k | VE / CA 2020 | - |
PER 2019 |
3,09
x | PER 2020 |
-1,77
x | Employés | - |
Rendement 2019 * |
-
| Rendement 2020 |
-
| Flottant | 93,84% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | 70 | 22/12/03 | |
James Grainer
CHM | Chairman | 69 | 22/05/20 |
Lois Chandler
COO | Chief Operating Officer | - | 01/07/10 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Founder | 70 | 22/12/03 | |
James Grainer
CHM | Chairman | 69 | 22/05/20 |
Ronald Shebuski
CTO | Chief Tech/Sci/R&D Officer | 71 | 22/05/20 |
Varia. 1 janv. | Capi. | |
---|---|---|
+17,96% | 44,96 Md | |
+1,17% | 42,65 Md | |
+46,51% | 41,85 Md | |
-4,27% | 29,04 Md | |
+11,42% | 26,08 Md | |
-21,39% | 19,03 Md | |
+4,86% | 12,75 Md | |
+27,29% | 12,06 Md | |
-3,50% | 11,75 Md |